BioXcel Therapeutics (BTAI) PT Lowered to $10 at Goldman Sachs on Lower Igalmi Pricing
Tweet Send to a Friend
Goldman Sachs analyst Corinne Jenkins lowered the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
